Prostate cancer: estimating the benefits of PSA screening. Article uri icon

Overview

abstract

  • Two groundbreaking trials have this year reported conflicting results as to the benefit of screening for prostate cancer. Careful interpretation in the light of contemporary data is needed to reveal the value of this intervention.

publication date

  • June 1, 2009

Research

keywords

  • Biomarkers, Tumor
  • Mass Screening
  • Prostate-Specific Antigen
  • Prostatic Neoplasms

Identity

PubMed Central ID

  • PMC2862723

Scopus Document Identifier

  • 70349278598

Digital Object Identifier (DOI)

  • 10.1038/nrurol.2009.95

PubMed ID

  • 19498406

Additional Document Info

volume

  • 6

issue

  • 6